Content about Boots UK

December 9, 2013

BioElectronics on Monday announced that Boots will be selling its ActiPatch Pain Therapy products in select stores for back, knee and musculoskeletal ailments.

November 5, 2013

Walgreens and Alliance Boots on Tuesday announced that Richard Ashworth, Walgreens corporate operations VP for the Western United States, has been appointed as director of health care, health and beauty U.K. and Republic of Ireland at Alliance Boots.

September 20, 2013

Alliance Boots announced that it is establishing a specialized investment fund, B&B Capital Partners, which will be focused on small- and medium-sized consumer brand businesses within the health, wellness, beauty and personal care sectors.

June 21, 2013

No7 Men skin care products, part of the U.K.’s skin care brand No7 created by Boots, is now available chainwide at Walgreens and Duane Reade stores.

May 17, 2013

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse.

A couple days later, Alliance Boots along with Walgreens and AmerisourceBergen announced the necessary regulatory clearances on that strategic partnership, cementing the three companies in place as the largest generic pharmaceutical acquisition company in the world. That deal will further enable the company's to realize greater profit margins.

May 17, 2013

The deal that paired Walgreens and Alliance Boots with wholesaler AmerisourceBergen has received the required regulatory clearances, the companies announced Friday.

May 15, 2013

Alliance Boots on Wednesday reported a double-digit profit gain for its year ended March 31.

May 10, 2013

Alliance Boots on Friday announced that it has distributed its equity interest in Galenica, its Swiss associate, to the group’s ultimate parent company, AB Acquisitions Holdings, in accordance with the terms of the agreement with Walgreens reached last year.

April 22, 2013

To the skepticism of many, Walgreens last year made a big global splash with its two-step merger deal with Alliance Boots across the pond. But with the announcement that the co-joined Walgreens/Alliance Boots had signed a 10-year distribution deal with wholesaler AmerisourceBergen, that included an equity stake to boot, well, it seemed that many analysts on Wall Street finally got it.

March 27, 2013

Alliance Boots on Wednesday announced its contract manufacturing business BCM will invest heavier into core competency categories, such as beauty and skin care, as it discontinues third-party manufacturer development in unnamed "unprofitable" categories.

March 22, 2013

Walgreens and Alliance Boots entered into a 10-year contract with wholesaler AmerisourceBergen on sourcing pharmaceuticals last week. But that's not all. Besides the long-term contract, Walgreens and Alliance Boots will have the option on a potential 23% equity stake in ABC in three years.

The deal takes pharmaceutical buying leverage to the stratosphere and changes the face of more than one health service industry. As Adam Fein, president of Pembroke Consulting, noted in a live television interview on Fox Business' "Money With Melissa Francis": "Three of the largest companies in the pharmaceutical industry have come together and built the single largest buyer of prescription drugs in the world," he said.

March 19, 2013

Walgreens will no longer source branded prescription medicines directly from suppliers beginning in September, the Chicago-based retailer announced as part of a significant partnership between Walgreens, Alliance Boots and AmerisourceBergen that includes Walgreens and Alliance Boots potentially taking a 7% stake in the Pennsylvania wholesaler.

February 13, 2013

Walgreens and Alliance Boots will generate $130 billion or more in combined sales, Greg Wasson, Walgreens president and CEO told analysts Wednesday.

November 29, 2012

It’s a marriage of industry icons. In June, Walgreens finally made a long-awaited leap across the Atlantic to acquire British-based Alliance Boots, one of the world’s premier retailers of pharmaceuticals, health and beauty aids, and beauty care products. 


November 7, 2012

Boots U.K. recently took a page out of Walgreens' playbook with the placement of health guides across the front-end.

November 2, 2012

Alliance Boots on Thursday announced that it has acquired ownership of its associate, Alliance Healthcare Russia, from AB Acquisitions Holdings Limited, the ultimate parent company of Alliance Boots.

November 2, 2012

Omni-channel retailing is so yesterday. Omni-national retailing is the space where Walgreens is looking to play, and this magazine is just one of the first examples of how retailing concepts from the Old Country will be imported from across the Pond and translated for the U.S. market.

(THE NEWS: Walgreens launches new biannual magazine showcasing private label, Balance Rewards deals. For the full story, click here.)

October 31, 2012

Walgreens on Tuesday announced that it has formally set up a new company, jointly owned with Alliance Boots, as part of their strategic partnership’s synergy program.

September 25, 2012

In June, Walgreens announced a two-step investment in a strategic partnership with Alliance Boots, to acquire a 45% equity stake in the privately held company for $6.7 billion in cash and stock in the first step with the option to acquire the other 55% approximately three years down the road at what is today being projected to be another $9.5 billion price tag in cash and stock. 


September 25, 2012

As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


September 20, 2012

Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million.

© 2014 Drug Store News. All Rights Reserved.